Banner Image

The Washington Post: Prescription Drug Prices Jumped More than 10 Percent in 2015

Jan 11, 2016 | News
Drug prices were big news in 2015, thanks in large part to Martin Shkreli, who drew outrage for hiking the price of a life-saving drug by 5,000 percent.
Read more ▸▸

The Columbus Dispatch: Drug Prices up More than 10 Percent in 2015

Jan 11, 2016 | News
Prescription drug prices rise more than 10 percent in 2015 well in excess of the U.S. inflation rate - according to an analysis released Monday by Truveris.
Read more ▸▸

Business Insurance: Prescription Drug Prices Jumped More than 10 Percent in 2015

Jan 11, 2016 | News
Drug prices were big news in 2015, thanks in large part to Martin Shkreli, who drew outrage for hiking the price of a life-saving drug by 5,000 percent.
Read more ▸▸

Specialty Pharma Journal: New Report Finds Prescription Drug Prices Rose 10.43 Percent in 2015

Jan 11, 2016 | News
Prescription drug prices rose 10.43 percent in 2015 – squeezing American household budgets and adding fuel to the debate around healthcare costs.
Read more ▸▸

Chicago Tribune: Prescription Drug Prices Jumped More than 10 Percent in 2015,

Jan 11, 2016 | News
Prescription drug prices rise more than 10 percent in 2015 well in excess of the U.S. inflation rate - according to an analysis released Monday by Truveris.
Read more ▸▸

St. Louis Post-Dispatch: Prescription Drug Prices Jumped More Than 10 Percent in 2015,

Jan 11, 2016 | News
Prescription drug prices rise more than 10 percent in 2015 well in excess of the U.S. inflation rate - according to an analysis released Monday by Truveris.
Read more ▸▸

InsuranceNewsNet: Prescription Drug Prices Climbed 10.43% in 2015

Jan 11, 2016 | News
Prescription drug prices rose 10.43 percent in 2015 – squeezing American household budgets and adding fuel to the debate around healthcare costs.
Read more ▸▸

Reuters: Pfizer Hikes U.S. Prices for Over 100 Drugs on January 1

Jan 8, 2016 | News
Pfizer Inc on Jan. 1 raised U.S. prices for more than 100 of its drugs, some by as much as 20 percent, according to statistics compiled by Wolters Kluwer.
Read more ▸▸

The Traverse City Record Eagle: No COLA Increase Should Infuriate and Energize Seniors

Oct 27, 2015 | News
About 65 million seniors were informed on Oct. 15 that there would be no Social Security annual cost of living adjustment (COLA) for 2016.
Read more ▸▸

American Journal of Managed Care: 2015 Sees a More Gradual Slope to Prescription Drug Prices

Oct 27, 2015 | News
A new analysis by the healthcare technology firm Truveris, reports that prescription drug prices rose 9.1% through September 30, 2015, for all medicines.
Read more ▸▸

Fortune: Why the Drug Price Scandal won’t be Enough to Keep Down Prices

Oct 26, 2015 | News
Daraprim captured national attention in September when Turing Pharmaceuticals boosted the price of the lifesaving toxoplasmosis treatment by over 5,000%.
Read more ▸▸

Pharmalot: Prescription Drug Price Hikes are Slowing this Year

Oct 26, 2015 | News
The price tags for prescription drugs are a red-hot issue that is increasingly causing concern among consumers, physicians and insurers.
Read more ▸▸

Drug Channels: Three Ways The C-Suite Can Prepare for the Cadillac Tax

Oct 23, 2015 | News
Leon discusses “the Cadillac tax,” a federal tax employers will pay on higher priced employee health benefit plans.
Read more ▸▸

Chief Executive: Pharma CEOs Grapple With Huge R&D Costs

Oct 22, 2015 | News
Turing Pharmaceuticals CEO Martin Shkreli hiked the price of Daraprim—a drug used to treat patients with AIDS, cancer, and malaria—by about 5,445%.
Read more ▸▸

TheStreet: Prescription Drug Costs Rising Again Even Among Generic Medications

Oct 21, 2015 | News
Prescription drug prices are expected to spike again, especially among some generic medications, following last year’s swift increase.
Read more ▸▸

MainStreet: Prescription Drug Costs Rise Again

Oct 21, 2015 | News
Prescription drug prices are expected to spike again, especially among some generic medications, following last year’s swift increase.
Read more ▸▸

USA Today: Stagnant Social Security Check Could Pose Hardship for Some

Oct 16, 2015 | News
Millions of Social Security recipients who depend on the program for most of their income will have to cut back on necessities such as food and medical care.
Read more ▸▸

Xconomy: Q&A with Biotech Venture Vet Nina Kjellson

Sep 30, 2015 | News
Nina Kjellson has been a biotech investor for 15 years, having spent the last 13 at InterWest Partners in Menlo Park, CA, and now moving to Canaan Partners.
Read more ▸▸

Fortune: Q&A with Memorial Sloan Kettering’s Dr. Peter B. Bach

Sep 29, 2015 | News
Drug prices have taken center stage since Turing Pharmaceuticals raised the price of its off-patent parasite-fighting drug Daraprim by over 5,000%.
Read more ▸▸

Mic: Hedge Fund Manager's Turing Pharmaceuticals Raises 62-Year-Old Drug From $13.50 to $750

Sep 21, 2015 | News
Daraprim used to cost just $13.50 per dose. Now it's $750 for each and every tablet.
Read more ▸▸

CNBC: More Americans Cut Spending to Pay for Prescription Drugs

Aug 18, 2015 | News
One-third of Americans who regularly take prescription medication are seeing price hikes this year.
Read more ▸▸

New App Helps Consumers Find More Ways to Save on Prescription Drugs

Aug 5, 2015 | Press Releases
OneRx enables consumers to review drug pricing and benefits data, offering the most robust prescription drug savings tool in the marketplace.
Read more ▸▸

The Washington Post: How new drugs helping millions of Americans live longer are also making them go broke

Jun 30, 2015 | News
If you pay for good health insurance, shouldn’t you be able to afford the medicine you need?
Read more ▸▸

Employee Benefit News: Plan Design Changes Required to Curb Rising Rx Drug Prices

May 1, 2015 | News
Prescription drug prices jumped another 3.8% in the first quarter of 2015, adding to the fears of employers concerned about increasing health care costs.
Read more ▸▸

Employee Benefit News: Generic Drugs Beat Explosive Price Trends in Health Plans

May 1, 2015 | News
Generic pharmaceuticals have maintained their “laggard” status compared to branded and specialty drugs with respect to rising prices.
Read more ▸▸

Valued Pharmacy Services: 2015 Prescription Drug Prices Jump Another 3.8% in Q1, According to Truveris National Drug Index

Apr 29, 2015 | News
Truveris continues to spotlight prescription drug cost increases with 2015 data from the Truveris National Drug Index (NDI).
Read more ▸▸

2015 Prescription Drug Prices Jump Another 3.8% in Q1, According to Truveris National Drug Index

Apr 28, 2015 | Press Releases
Truveris continues to spotlight prescription drug cost increases with 2015 data from the Truveris National Drug Index (NDI).
Read more ▸▸

Life Health Pro: Stop-Loss, The Market Plumbers

Mar 20, 2015 | News
Some of the bigger small employers are thinking of stop-loss programs as a health benefits life raft.
Read more ▸▸

American Pharmacy News: Truveris Launches Pharmacy Stop Loss Insurance Platform

Mar 17, 2015 | News
Truveris introduces a new product that will enable benefits brokers and advisers to help companies take advantage of stop loss insurance.
Read more ▸▸

Bloomberg News: The Drug Pipeline Flows Again

Feb 26, 2015 | News
One new drug, Bristol-Myers Squibb’s Opdivo, boosted one-year survival rates in trials to 73 percent from 42 percent for standard chemotherapy.
Read more ▸▸

Financial Times: The Race to Cure Rising Drug Costs

Feb 10, 2015 | News
Since contracting hepatitis C 25 years ago, Lucinda Porter’s biggest fear has been that she would infect someone else with the deadly virus. “Whenever I cut myself and saw the smeared blood, I would panic,” she says.
Read more ▸▸

Aging Care: Did You Notice the Big Jump in Drug Costs from 2013 to 2014?

Feb 3, 2015 | News
If you’re an average citizen who required prescription medication in 2014, you paid about 10.9 percent more than you did in 2013.
Read more ▸▸

Business Journal: Branded Drug Prices Spike 15 Percent

Jan 30, 2015 | News
Branded drug prices spiked nearly 15% last year, according to the latest data from the Truveris National Drug Index.
Read more ▸▸

FiercePharma: Branded Drug Prices Leapt Almost 15% Last Year, Led by Pain Pills, COPD and Heart Meds

Jan 29, 2015 | News
U.S. consumers saw prescription med prices vault 10.9% in 2014, according to the Truveris National Drug Index.
Read more ▸▸

Healthy Skeptic: Truveris Drug Price Index

Jan 28, 2015 | News
The Truveris National Drug Index gathers and publishes data on medication pricing.
Read more ▸▸

Clinical Informatics News: Drug Prices Rose Across Classes in 2014

Jan 28, 2015 | News
On Monday, the Truveris National Drug Index released its first full year figures. In 2014, generic and specialty drugs combined rising 10.9%.
Read more ▸▸

The Wall Street Journal: Prices for Prescription Medicines Rose How Much Last Year?

Jan 26, 2015 | News
The prices of prescription medicines is a front-and-center issue as the cost to treat everything from some of the rarest diseases to the most common afflictions is causing increasing concern among payers, physicians and consumers.
Read more ▸▸

Americans Faced Double Digit Increases in Prescription Drug Prices in 2014, According to Truveris National Drug Index

Jan 26, 2015 | Press Releases
Americans faced double-digit price increases for prescription medications in 2014, according to the Truveris National Drug Index.
Read more ▸▸

Truveris Debuts NDI National Drug Index

Nov 19, 2014 | Press Releases
Truveris Debuts NDI National Drug Index
Read more ▸▸

LA Times: What's behind the huge price jump for some generic drugs?

Oct 20, 2014 | News
That's a question many consumers have been asking lately. And now, a pair of prominent congressmen are demanding an answer from the drug industry.
Read more ▸▸

Forbes: Delivering On Big Data For Verticals, Truveris Helps Pharmacy Industry Work Smarter

Aug 20, 2014 | News
The benefits that applying analytics to data has long been understood. But generally the big data solutions we’ve seen thus far have been targeted towards broad horizontal opportunities.
Read more ▸▸

Crain’s New York: Digital health startup rides funding wave

Jun 27, 2014 | News
Hudson Square-based Truveris becomes the latest beneficiary of the Obamacare-powered surge in funding for digital health care analysis, snagging $12.8 million in new capital.
Read more ▸▸

Pharmacy Pricing & Benefits Analysis Platform Truveris Raised Another $12.75M

Jun 27, 2014 | Press Releases
Truveris raises $12.8M in Series C
Read more ▸▸

TechCrunch: Prescription auditing service Truveris raises $12.75 million

Jun 26, 2014 | News
Bringing clarity to the $300 billion prescription drug payment system in the U.S., Truveris has raised $12.75 million in a new round of funding led by Canaan Partners.
Read more ▸▸